TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: cocaine-induced increases in cardiovascular measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: local inoculation-site side effects
Endpoint domain: Adverse events/effects
Primary endpoint: herpes zoster occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Mean microshear bond strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: between-observer repeatability of differential cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of total surgical effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nonserious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Michigan Hand Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Disabling strokes
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of epileptiform and slow activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Alpha amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Predictive value of EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: microshear bond strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean AUCt of doxylamine hydrogen succinate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Cmax of doxylamine hydrogen succinate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Somnolence as an adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Fasting plasma glucose change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean body weight change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement of recalled quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Agreement of recalled function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Agreement of recalled general health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MDI total scoring for SLE related damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS15 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial stiffness (cfPWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: KAT 2000 static and dynamic scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TUGT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WS and ABC Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum excursion distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip adduction excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IFN‐γ ELISpot response rate to Gag
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PpIX fluorescence intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluorescence contrast between normal and malignant urothelial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking cessation at 1-year follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MVC of knee extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functional measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in alcohol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in dealing with breathing problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nalbuphine consumption in the first 24 h after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity score on sitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mucous fern pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: haemoglobin drop > 2 g/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PCR-corrected adequate clinical and parasitological response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SCH (Stratum Corneum Hydration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cure rates at the test-of-cure assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHD‐RS‐IV School Version total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHD‐RS‐IV Home Version total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression - Improvement (CGI‐I)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Minutes of daily MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 5-year Progression-Free Survival (PARFS)
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy of RIRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean hematocrit drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ankle CSAE score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee CSAE score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Written test score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to recovery to an Aldrete score of 9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alpha-T: gamma-T ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum gamma-T levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: free PSA:total PSA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxidative stress markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: new cases of type 2 diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity of clinical risk variables and PlGF measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-test probability of developing preterm pre-eclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients attaining LDL-C goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pulmonary flow velocity response to acetylcholine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: sudden gains in treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depression levels post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blood pressure drop during spinal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTx levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak CK-MB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Temporary normalization of tympanometric findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response time to sertraline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rates to single-drug therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VLDL-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in US B-lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in dry weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in LV filling pressures (E/e' ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean total fluoroscopy time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3000 meter running performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of developing oral cancer
Endpoint domain: Mortality/survival
Primary endpoint: Cost per procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sleep disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month recovery status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: survival rate of restorative materials
Endpoint domain: Mortality/survival
Primary endpoint: Ammonia concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ongoing implantation rate
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in ambiguous atypical squamous cells of undetermined significance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of squamous intraepithelial lesion and cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: platelet aggregation inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Angiotensin II levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surfactant protein D concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased 10-minute MVPA bouts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global communication skills
Endpoint domain: Life impact
Endpoint subdomain: Communication
Primary endpoint: involvement of significant others
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Endothelial function (EDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Cost of medications
Endpoint domain: Resource use
Primary endpoint: Improvement of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement of concentration difficulties
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Working hours
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: overall asthma symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AQL score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction of circulating IL-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mouse allergen levels on the bedroom floor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma-related sleep and activity disturbance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: quadriceps peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-placement test scores of knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-placement test scores of skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual acuity assessment test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response conflict solving speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of unhealthy alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desire to continue six-monthly monitoring
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: composite of death or myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: overall cost of treating a patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: rate of target vessel revascularisation (TVR)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall score sensitivity and reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Arteriovenous passage times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in PIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transfusion rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in physical activity goals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of study using minimum number of sensors
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability of wearable technologies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: revision surgery/re-hospitalization rate
Endpoint domain: Adverse events/effects
Primary endpoint: Deterioration of chronic pain syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to anticoagulation control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of sacroiliac joint pain provocation tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of mothers who bed shared with their newborn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-related Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: accuracy improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suppression of activation in vmPFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Expression rate of CD80
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proliferation capacities of IL‐12 and T lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: drainage time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean tmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean AUC(0-3 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum concentration of 70 micromol/l or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of mexiletine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in hippocampi Dmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Radiation dose outcomes
Primary endpoint: Reduction in optic nerve Dmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Radiation dose outcomes
Primary endpoint: Reduction in lens Dmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Radiation dose outcomes
Primary endpoint: Walking to or from school
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Myocardial injury markers above normal limit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postprocedural peak levels of creatine kinase-MB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak reactive hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trapped gas volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Progressive decalcification of teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SBP z scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of overall prophylactic failure
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Clostridium difficile infection
Endpoint domain: Adverse events/effects
Primary endpoint: Expressive vocabulary scores in older toddlers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receptive vocabulary scores in older toddlers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS Score <3
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Psychological aspects of HRQoL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in HFS severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mixed venous saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: systemic saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: oxygen excess factor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HP eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pain reduction during recovery phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: episodes of intermittent hypoxemia per 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: proportion of time with oxygen saturations <85%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean hydration score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total wrinkle count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average wrinkles severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quadriceps strength as a percentage of baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: MEDFICTS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain relief (visual analogue scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxalate excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Phosphate excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Citrate excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pain relief measured by SPID score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient rating of pain relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of CR-BSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Costs per catheter used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: P2Y12 percentage inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: tolerability of the FDC formulation
Endpoint domain: Adverse events/effects
Primary endpoint: Serum TB12 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC(glucose) after OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rejection surveillance strategies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of normal tissue complication probability (NTCP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tinetti balance test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incident falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinach intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in DSI (Dysphonia Severity Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obstructive Sleep Apnea (OSA) prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type 2 diabetes prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pre-diabetes prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CD4 CD45ro cell numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes